Dextrose 5% in water clinical trials

Low-Dose IL-2 For The Reduction Of Vascular Inflammation In ACS -Clinical Outcomes & Follow-up Study

This study is checking on people who previously took part in the IVORY trial. It's looking at whether a low dose of a medicine called IL-2 helped reduce heart problems in people who had a heart attack, by lowering inflammation in their blood vessels.